Speak to the pharma team
01628 581 240
Speak to the healthcare team
01225 336 335
Speak to the clinical team
01628 581 240
Speak to the contract team
01225 336 335
Speak to us about Master Vendor
01225 336 335
Or send your enquiry via email and the best person to help will be in touch.
solutions@starmedical.co.uk
IVAX operates in North and Latin America, Europe and Asia and is a top 10 UK pharmaceutical company. Their mission is to improve the health of their customers with their high-quality pharmaceuticals and to "operate as an ethical and honourable corporate citizen".
IVAX researches, develops and sells branded and generic pharmaceuticals. With over 300 product lines, they are a UK leader in first-to-market generic alternatives sold through wholesales, pharmacy chains, independent pharmacists and hospitals.
Proud of their research and development, IVAX spent $76 million in 2002 on research and development to create a powerful product pipeline. In 2004 they produced over 60 million inhalers, 2 billion tablets, 35 million patient packs and 200 million sterile liquid unit doses for the UK and International markets.
IVAX market a variety of asthma drugs in aerosol and non-aerosol dry-powder formulations. They also promote Steri_neb formulations for use in nebulisers for the treatment of COPD and asthma.
Products in the UK IVAX market include:
Qvar and Easi-breathe inhalers
Mucodyne to thin mucus for use in treatment of COPD and glue ear
